Latest AI and machine learning research in other cancers for healthcare professionals.
OBJECTIVE: This study aims to evaluate the diagnostic value of machine learning-based MRI imaging in differentiating benign and malignant prostate cancer and detecting clinically significant prostate cancer (csPCa, defined as Gleason score ≥7) using systematic review and meta-analysis methods. METHODS: Electronic databases (PubMed, Web of Science, Cochrane Library, and Embase) were systematically ...
In this study, we introduce MILK10k, a multimodal image dataset designed to enhance machine learning and artificial intelligence-driven applications for diagnosing skin lesions suspected to be malignant neoplasms. MILK10k includes both close-up and dermatoscopy images expanding upon existing datasets with several enhancements. It expands disease coverage to 48 International Skin Imaging Collaborat...
The systematic literature review was performed on the use of artificial intelligence (AI) algorithms in nonsmall cell lung cancer (NSCLC) prognosticat...
Oral drug delivery remains a clinically preferred route for colorectal cancer therapy due to its noninvasive nature and patient compliance. However, c...
The type IA topoisomerase subfamily includes bacterial topoisomerase I and topoisomerase III encoded by topA and topB genes, reverse gyrase found in t...
Endocervical adenocarcinoma (ECA) the fatal and intrusive subtype of cervical carcinoma is on rise from the last decade. Its improper detection leads ...
Breast cancer remains the most prevalent cause of cancer-related mortality among women worldwide, with an estimated incidence exceeding 500,000 new ca...
The brain tumours originate in the brain or its surrounding structures, such as the pituitary and pineal glands, and can be benign or malignant. While...
Colorectal cancer (CRC) exhibits substantial heterogeneity in molecular subtypes and clinical outcomes. We performed an integrative analysis of multi-...
Hilar cholangiocarcinoma (hCCA), a rare cancer of the biliary system, has a poor prognosis. This study aimed to investigate the risk factors affecting...
Skin cutaneous melanoma (SKCM) is a fatal form of skin cancer. Metabolism-related genes (MRGs) comprise a group of genes that possess the ability to m...
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer-related death. Cirrhosi...
Diffusion-weighted imaging (DWI) has become a cornerstone of high-resolution rectal MRI, providing critical functional information that complements T2...
Lung cancer is a prevalent and lethal malignancy characterised by the uncontrolled growth of abnormal cells in lung tissues, often leading to function...
BACKGROUND: Surgeons often face challenges in distinguishing between benign and malignant follicular thyroid neoplasms (FTNs), particularly small tumo...
Hepatocellular carcinoma (HCC) progression and prognosis are influenced by various molecular markers. This study aimed to identify the hub gene associ...
Despite decades of research, cancer remains a growing global health challenge. Nanomaterials-based therapeutics have shown promise, but their clinical...
Predicting the risk of breast cancer recurrence is crucial for guiding therapeutic strategies, including enhanced surveillance and the consideration o...
Breast cancer continues to be a leading cause of death among women in the world. The prediction of survival outcomes based on treatment modalities, i....
With the shift toward de-escalating surgery in breast cancer, prediction models incorporating imaging can reassess the need for surgical axillary stag...